| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Sidney Kimmel Comprehensive Cancer Center and 2 Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Requests for reprints: James G. Herman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Suite 541, 1650 Orleans Street, Baltimore, MD 21231. Phone: 410-955-8506; Fax: 410-614-9884; E-mail: hermanji{at}jhmi.edu.
hTERT, which encodes the catalytic subunit of telomerase and is expressed in most immortalized and cancer cells, has been reported to have increased DNA methylation in its promoter region in many cancers. This pattern is inconsistent with observations that DNA methylation of promoter CpG islands is typically associated with gene silencing. Here, we provide a comprehensive analysis of promoter DNA methylation, chromatin patterns, and expression of hTERT in cancer and immortalized cells. Methylation-specific PCR and bisulfite sequencing of the hTERT promoter in breast, lung, and colon cancer cells show that all cancer cell lines retain alleles with little or no methylation around the transcription start site despite being densely methylated in a region 600 bp upstream of the transcription start site. By real-time reverse transcription-PCR, all cancer cell lines express hTERT. Chromatin immunoprecipitation (ChIP) analysis reveals that both active (acetyl-H3K9 and dimethyl-H3K4) and inactive (trimethyl-H3K9 and trimethyl-H3K27) chromatin marks are present across the hTERT promoter. However, using a novel approach combining methylation analysis of ChIP DNA, we show that active chromatin marks are associated with unmethylated DNA, whereas inactive marks of chromatin are associated with methylated DNA in the region around the transcription start site. These results show that DNA methylation patterns of the hTERT promoter (150 to +150 around the transcription start) are consistent with the usual dynamics of gene expression in that the absence of methylation in this region and the association with active chromatin marks allow for the continued expression of hTERT. [Cancer Res 2007;67(1):194201]
This article has been cited by other articles:
![]() |
P. Novak, T. J. Jensen, J. C. Garbe, M. R. Stampfer, and B. W. Futscher Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization Cancer Res., June 15, 2009; 69(12): 5251 - 5258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chatagnon, S. Bougel, L. Perriaud, J. Lachuer, J. Benhattar, and R. Dante Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells Carcinogenesis, January 1, 2009; 30(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Srivastava, J. Guo, H. Shi, and D. Xu PRIMEGENS-v2: genome-wide primer design for analyzing DNA methylation patterns of CpG islands Bioinformatics, September 1, 2008; 24(17): 1837 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, J. Dwyer, H. Li, W. Duan, and J.-P. Liu Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc J. Biol. Chem., August 29, 2008; 283(35): 23567 - 23580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D.F. Licchesi, W. H. Westra, C. M. Hooker, and J. G. Herman Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung Clin. Cancer Res., May 1, 2008; 14(9): 2570 - 2578. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |